Pharma Pulse: Updates in the Pharmaceutical Industry
This episode of Pharma Pulse discusses recent developments in the pharmaceutical industry, including Mark Cuban's direct-to-consumer pharmacy and its impact on traditional drug pricing models.
- Mark Cuban's pharmacy challenges traditional drug pricing models.
- AstraZeneca invests $4.5 billion to expand its Virginia manufacturing site.
- Bristol Myers Squibb acquires Orbital Therapeutics for $1.5 billion to advance RNA-based medicines.
These developments reflect a fast-evolving landscape for pharma strategy and patient access, focusing on cost transparency, domestic manufacturing, and next-generation RNA innovation.
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation.
Author's summary: Pharma Pulse covers industry updates.
More News
- Trump Has Merged the War on Gangs and Immigration. Tennessee Shows How.
- Brendan Gallagher: Furious little bull who was as hard as nails
- Coast Guard and National Guard crews have now rescued 51 from Alaska floods
- Perfect Pitch: The Life of a Showgirl
- A Saint for our time: The canonization of Archbishop Ignatius Maloyan
- Liberty Hall to reprise its role as an opera house for centennial anniversary screening with live piano accompaniment
- Brendan Gallagher: No-one is immune to this awful disease
- Martin won't give up on Stawell dream, but for now the 400m is his focus
- Brio and Bravo get strategic investment from R&R Brands
- UVA faculty rejects Trump administration's Compact for Academic Excellence